Bulletin
Investor Alert

New York Markets Close in:

Market Snapshot Winners and Losers

HilleVax Inc.

NAS: HLVX

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
HilleVax Inc.

Market open

HLVX
/zigman2/quotes/234952647/composite

$

10.50

Change

0.00 0.00%

Volume

Volume 310

Jul 5, 2022, 9:30 a.m.

Real time quotes

/zigman2/quotes/234952647/composite

Previous close

$ 10.50

$ 10.50

Change

0.00 0.00%

Day low

Day high

$10.50

$10.50

Open
Open: 10.50

52 week low

52 week high

$7.90

$20.95

Open

Market cap

$350.99M

Average volume

277,060

P/E ratio

N/A

Rev. per Employee

N/A

EPS

N/A

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/hlvx

MarketWatch News on HLVX

  1. HilleVax started at buy with $34 stock price target at Stifel Nicolaus

    7:50 a.m. May 24, 2022

    - Tomi Kilgore

  2. HilleVax started at overweight with $24 stock price target at J.P. Morgan

    7:11 a.m. May 24, 2022

    - Tomi Kilgore

/news/nonmarketwatch/company/us/hlvx

Other News on HLVX

  1. Norovirus vaccine developer HilleVax stock jumps 23%

    4:10 p.m. June 23, 2022

    - Seeking Alpha

  2. 10-Q: HILLEVAX, INC.

    4:28 p.m. June 8, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  3. HilleVax stock jumps 11% following four analyst buy ratings

    1:25 p.m. May 24, 2022

    - Seeking Alpha

  5. HilleVax prices IPO at $17 per share, debuts today

    7:36 a.m. April 29, 2022

    - Seeking Alpha

  7. Novovirus vaccine developer HilleVax files for $100M IPO

    3:15 p.m. April 18, 2022

    - Seeking Alpha

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.